PsyBio Therapeutics Corp
OTC: PSYBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Evan Levine
- Employees
- 118
- Headquarters
- Denver, United States
- IPO year
- 2021
- Market cap
- $1.3K
- Website
- https://www.psybiolife.com
Loading PSYBF…
Loading profile data…Frequently asked questions about PSYBF
What does PsyBio Therapeutics Corp (PSYBF) do?
PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company was founded on October 28, 2009 and is headquartered in Sunrise, FL.
Where does PSYBF trade?
PsyBio Therapeutics Corp (PSYBF) trades on the Other OTC.
What sector is PSYBF in?
PsyBio Therapeutics Corp (PSYBF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of PsyBio Therapeutics Corp?
Evan Levine is the chief executive officer of PsyBio Therapeutics Corp (PSYBF).
Where is PsyBio Therapeutics Corp headquartered?
PsyBio Therapeutics Corp is headquartered in United States.
Does PSYBF pay a dividend?
PsyBio Therapeutics Corp (PSYBF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PSYBF go public?
PsyBio Therapeutics Corp (PSYBF) completed its initial public offering in 2021.